MENU

Immunic (IMUX) Ownership - Who owns Immunic?

Profile

Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
77
Web
https://www.imux.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
131.52M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
1.13M
Revenue
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IMUX
Capitalization
132M
P/E Ratio
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
1.13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
83.6M
P/B Ratio
1.57
Cash Flow
N/A
Earnings
-1.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
5.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-95.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-91.94
Shares Held By Institutions
79.9M
Shares Outstanding - Current
90.1M
Total Liabilities
20.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-2.667
View a ticker or compare two or three
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
77
Web
https://www.imux.com